Search by Drug Name or NDC
NDC 69489-0212-07 ZILXI 15 mg/g Details
ZILXI 15 mg/g
ZILXI is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Journey Medical Corporation. The primary component is MINOCYCLINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Minocycline topical is used to treat certain types of acne in adults and children 9 years of age and older. Minocycline is in a class of medications called tetracycline antibiotics. It works to treat acne by killing the bacteria that infects pores and decreasing a certain natural oily substance that causes acne.
Related Packages: 69489-0212-07Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Minocycline Topical
Product Information
| NDC | 69489-0212 |
|---|---|
| Product ID | 69489-212_4ab22cac-50b3-4814-8eac-a6c41700462b |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | ZILXI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Minocycline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | AEROSOL, FOAM |
| Route | TOPICAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/g |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Labeler Name | Journey Medical Corporation |
| Pharmaceutical Class | Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA213690 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69489-0212-07 (69489021207)
| NDC Package Code | 69489-212-07 |
|---|---|
| Billing NDC | 69489021207 |
| Package | 1 CAN in 1 CARTON (69489-212-07) / 7 g in 1 CAN |
| Marketing Start Date | 2022-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |